| Johanna Schubert, MD | |
|
601 N 30th St, Omaha, NE 68131-2137 | |
| (402) 449-5435 | |
| Not Available |
| Full Name | Johanna Schubert |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 23 Years |
| Location | 601 N 30th St, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134353923 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | NOT SURE (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi Health Bergan Mercy | Omaha, NE | Hospital |
| Cass County Memorial Hospital | Atlantic, IA | Hospital |
| Chi Health Lakeside | Omaha, NE | Hospital |
| Clarinda Regional Health Center | Clarinda, IA | Hospital |
| Myrtue Medical Center | Harlan, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiology Consultants Pc | 8325947799 | 42 |
| Think Aksarben Llc | 9638394505 | 87 |
| Radiology Consultants Pc | 8325947799 | 42 |
News Archive
A new study from Children's Hospital of Philadelphia finds that a skin patch may be useful in treating children with a painful, chronic condition called eosinophilic esophagitis triggered by milk.
BioLight Life Sciences Investments, a company focused primarily on the discovery, development and commercialization of breakthrough ophthalmic diagnostics and therapeutics, announced today that it has entered into a joint financing agreement (the "Agreement") with two Asia-based venture capital firms (the "New Investors"), pursuant to which BioLight and the New Investors will make a direct equity investment in BioLight's IOPtima Ltd. subsidiary via a private placement.
A study out of Drexel University's Dornsife School of Public Health linked past experiences with bias and discrimination and avoidance of doctors in women with higher body weights.
For the first time gene therapy for cystic fibrosis has shown a significant benefit in lung function compared with placebo, in a phase 2 randomised trial published in The Lancet Respiratory Medicine journal. The technique replaces the defective gene response for cystic fibrosis by using inhaled molecules of DNA to deliver a normal working copy of the gene to lung cells.
› Verified 8 days ago
| Entity Name | Radiology Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215969407 PECOS PAC ID: 8325947799 Enrollment ID: O20040105000605 |
News Archive
A new study from Children's Hospital of Philadelphia finds that a skin patch may be useful in treating children with a painful, chronic condition called eosinophilic esophagitis triggered by milk.
BioLight Life Sciences Investments, a company focused primarily on the discovery, development and commercialization of breakthrough ophthalmic diagnostics and therapeutics, announced today that it has entered into a joint financing agreement (the "Agreement") with two Asia-based venture capital firms (the "New Investors"), pursuant to which BioLight and the New Investors will make a direct equity investment in BioLight's IOPtima Ltd. subsidiary via a private placement.
A study out of Drexel University's Dornsife School of Public Health linked past experiences with bias and discrimination and avoidance of doctors in women with higher body weights.
For the first time gene therapy for cystic fibrosis has shown a significant benefit in lung function compared with placebo, in a phase 2 randomised trial published in The Lancet Respiratory Medicine journal. The technique replaces the defective gene response for cystic fibrosis by using inhaled molecules of DNA to deliver a normal working copy of the gene to lung cells.
› Verified 8 days ago
| Entity Name | Alegent Creighton Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548287907 PECOS PAC ID: 1951210418 Enrollment ID: O20040407001314 |
News Archive
A new study from Children's Hospital of Philadelphia finds that a skin patch may be useful in treating children with a painful, chronic condition called eosinophilic esophagitis triggered by milk.
BioLight Life Sciences Investments, a company focused primarily on the discovery, development and commercialization of breakthrough ophthalmic diagnostics and therapeutics, announced today that it has entered into a joint financing agreement (the "Agreement") with two Asia-based venture capital firms (the "New Investors"), pursuant to which BioLight and the New Investors will make a direct equity investment in BioLight's IOPtima Ltd. subsidiary via a private placement.
A study out of Drexel University's Dornsife School of Public Health linked past experiences with bias and discrimination and avoidance of doctors in women with higher body weights.
For the first time gene therapy for cystic fibrosis has shown a significant benefit in lung function compared with placebo, in a phase 2 randomised trial published in The Lancet Respiratory Medicine journal. The technique replaces the defective gene response for cystic fibrosis by using inhaled molecules of DNA to deliver a normal working copy of the gene to lung cells.
› Verified 8 days ago
| Entity Name | Think Aksarben Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316357676 PECOS PAC ID: 9638394505 Enrollment ID: O20140819000301 |
News Archive
A new study from Children's Hospital of Philadelphia finds that a skin patch may be useful in treating children with a painful, chronic condition called eosinophilic esophagitis triggered by milk.
BioLight Life Sciences Investments, a company focused primarily on the discovery, development and commercialization of breakthrough ophthalmic diagnostics and therapeutics, announced today that it has entered into a joint financing agreement (the "Agreement") with two Asia-based venture capital firms (the "New Investors"), pursuant to which BioLight and the New Investors will make a direct equity investment in BioLight's IOPtima Ltd. subsidiary via a private placement.
A study out of Drexel University's Dornsife School of Public Health linked past experiences with bias and discrimination and avoidance of doctors in women with higher body weights.
For the first time gene therapy for cystic fibrosis has shown a significant benefit in lung function compared with placebo, in a phase 2 randomised trial published in The Lancet Respiratory Medicine journal. The technique replaces the defective gene response for cystic fibrosis by using inhaled molecules of DNA to deliver a normal working copy of the gene to lung cells.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Johanna Schubert, MD 601 N 30th St, Omaha, NE 68131-2137 Ph: () - | Johanna Schubert, MD 601 N 30th St, Omaha, NE 68131-2137 Ph: (402) 449-5435 |
News Archive
A new study from Children's Hospital of Philadelphia finds that a skin patch may be useful in treating children with a painful, chronic condition called eosinophilic esophagitis triggered by milk.
BioLight Life Sciences Investments, a company focused primarily on the discovery, development and commercialization of breakthrough ophthalmic diagnostics and therapeutics, announced today that it has entered into a joint financing agreement (the "Agreement") with two Asia-based venture capital firms (the "New Investors"), pursuant to which BioLight and the New Investors will make a direct equity investment in BioLight's IOPtima Ltd. subsidiary via a private placement.
A study out of Drexel University's Dornsife School of Public Health linked past experiences with bias and discrimination and avoidance of doctors in women with higher body weights.
For the first time gene therapy for cystic fibrosis has shown a significant benefit in lung function compared with placebo, in a phase 2 randomised trial published in The Lancet Respiratory Medicine journal. The technique replaces the defective gene response for cystic fibrosis by using inhaled molecules of DNA to deliver a normal working copy of the gene to lung cells.
› Verified 8 days ago
Dr. Timothy Edward Donovan, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-1010 Fax: 102-559-1011 | |
Mary S. Davey, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 601 N 30th St Ste 3601, Omaha, NE 68131 Phone: 402-449-4540 | |
Craig W Walker, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 988102 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-1010 Fax: 402-559-1011 | |
Steven T Mccormack, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 17310 Wright St Ste 103, Omaha, NE 68130 Phone: 833-228-6889 Fax: 877-853-0376 | |
John Paul Haas, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-1010 Fax: 402-559-1011 | |
Andrew Greer, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 982055 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-7268 | |
Sushama P Kunnathil, MBBS Radiology Medicare: Accepting Medicare Assignments Practice Location: 988102 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-1010 Fax: 402-559-1011 |